Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
SGP

SpyGlass Pharma (SGP) stock: insider trades, news & valuation

Strong buying
Close · Oct 9, 2026 $24.92 +1.2% on the day -5.6% over 12 months 52-week range $17.56 – $29.68

Share price and insider trades

SGP closeInsider buyInsider sale
15202530MarAprMayJunJulAugSepOctBought $221,480,000 on 2026-02-09 · Ali Behbahani, Anthony A. Florence Jr., Bilal Arshad Khan, Carmen Chang, Edward T Mathers, Forest Baskett, Geoffrey B Pardo, Kirk G. Nielsen, Mohamad Makhzoumi, Nea 17 Gp, Llc, Paul Edward Walker, Ra Capital Healthcare Fund Lp, Rick Yang, Scott D Sandell, Vensana Capital I Gp, Llc
Bought, 12 months$221M
Sold, 12 months$0
Insiders buying15
Insiders selling0

SpyGlass Pharma insider trading at a glance (Oct 9, 2026): in the past 12 months, 15 insiders bought $221M and 0 sold $0 of SGP stock on the open market, including a cluster buy that began Feb 9, 2026.

SGP insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q1 2026: $221M bought (17 trades)$221MQ1 2026Q2 2026Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0—0
Q2 2026—0—0
Q1 2026$221M17—0

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day0.8×Last 5 sessions
Insiders' paper profit+$123MOn all tracked purchases +55.8%

Summary

Over the past 12 months, 15 SpyGlass Pharma, Inc. insiders reported open-market purchases totaling $221M, while 0 insiders reported sales totaling $0. The most recent cluster buy began on Feb 9, 2026, when 15 insiders bought a combined $221M. Among insiders with enough purchase history to measure, Ra Capital Healthcare Fund Lp (Director) has the highest Insider Score at 98.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Feb 11SEC Ra Capital Healthcare Fund LpDirector Buy 3,441,9665,966,439 held (+136%) $16.00 $55.1M +55.8% 98
Feb 11SEC Scott D Sandell10% Owner Buy 937,5006,035,038 held (+18%) $16.00 $15.0M +55.8% 23
Feb 11SEC Anthony A. Florence Jr.10% Owner Buy 937,5006,035,038 held (+18%) $16.00 $15.0M +55.8% 23
Feb 11SEC Edward T Mathers10% Owner Buy 937,5006,035,038 held (+18%) $16.00 $15.0M +55.8% 23
Feb 11SEC Carmen Chang10% Owner Buy 937,5006,035,038 held (+18%) $16.00 $15.0M +55.8% 23
Feb 11SEC Ali BehbahaniDirector Buy 937,5006,035,038 held (+18%) $16.00 $15.0M +55.8% —
Feb 11SEC Nea 17 Gp, Llc10% Owner Buy 937,5006,035,038 held (+18%) $16.00 $15.0M +55.8% —
Feb 11SEC Forest Baskett10% Owner Buy 937,5006,035,038 held (+18%) $16.00 $15.0M +55.8% 23
Feb 11SEC Paul Edward Walker10% Owner Buy 937,5006,035,038 held (+18%) $16.00 $15.0M +55.8% 23
Feb 11SEC Rick Yang10% Owner Buy 937,5006,035,038 held (+18%) $16.00 $15.0M +55.8% 23
Feb 11SEC Mohamad Makhzoumi10% Owner Buy 937,5006,035,038 held (+18%) $16.00 $15.0M +55.8% 23
Feb 11SEC Geoffrey B PardoDirector Buy 312,5002,187,513 held (+17%) $16.00 $5.0M +55.8% —
Feb 11SEC Ra Capital Healthcare Fund LpDirector Buy 248,0342,054,678 held (+14%) $16.00 $4.0M +55.8% 98
Feb 11SEC Bilal Arshad KhanDirector Buy 115,000251,427 held (+84%) $16.00 $1.8M +55.8% —
Feb 11SEC Bilal Arshad KhanDirector Buy 20,00025,450 held (+367%) $16.00 $320K +55.8% —
Feb 10SEC Kirk G. NielsenDirector Buy 165,0003,310,619 held (+5%) $16.00 $2.6M +55.8% —
Feb 10SEC Vensana Capital I Gp, Llc10% Owner Buy 165,0003,310,619 held (+5%) $16.00 $2.6M +55.8% —

Insiders at SpyGlass Pharma, Inc.

InsiderBoughtSoldLast filingScore
Ra Capital Healthcare Fund LpDirector $59.0M — Feb 11, 2026 98
Scott D Sandell10% Owner $15.0M — Feb 11, 2026 23
Anthony A. Florence Jr.10% Owner $15.0M — Feb 11, 2026 23
Edward T Mathers10% Owner $15.0M — Feb 11, 2026 23
Carmen Chang10% Owner $15.0M — Feb 11, 2026 23
Ali BehbahaniDirector $15.0M — Feb 11, 2026 —
Nea 17 Gp, Llc10% Owner $15.0M — Feb 11, 2026 —
Forest Baskett10% Owner $15.0M — Feb 11, 2026 23
Paul Edward Walker10% Owner $15.0M — Feb 11, 2026 23
Rick Yang10% Owner $15.0M — Feb 11, 2026 23
Mohamad Makhzoumi10% Owner $15.0M — Feb 11, 2026 23
Geoffrey B PardoDirector $5.0M — Feb 11, 2026 —
Kirk G. NielsenDirector $2.6M — Feb 10, 2026 —
Vensana Capital I Gp, Llc10% Owner $2.6M — Feb 10, 2026 —
Bilal Arshad KhanDirector $2.2M — Feb 11, 2026 —

SGP stock: common questions

Are SpyGlass Pharma, Inc. insiders buying SGP stock?

In the past 12 months, 15 insiders reported open-market purchases of SGP worth $221M. The latest was Director Ra Capital Healthcare Fund Lp bought $55.1M of SGP at $16.00 — first open-market purchase in our records; raises the stake by 136%.

Are SpyGlass Pharma, Inc. insiders selling SGP stock?

0 insiders reported sales worth $0 over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is SGP's 52-week range?

Over the past year SGP has traded between $17.56 and $29.68. It last closed at $24.92 on Oct 9, 2026.